Dr. Rangwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Medical Ctr
# 10
Durham, NC 27710Phone+1 919-681-2954
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011- Duke University HospitalResidency, Internal Medicine, 2005 - 2008
University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2011 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 368 citationsCombined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal CancerRyan B. Corcoran, Thierry André, Chloe E. Atreya, Jan H.M. Schellens, Takayuki Yoshino
Cancer Discovery. 2018-04-01 - 141 citationsIncreased production of sonic hedgehog by ballooned hepatocytes.Fatima A. Rangwala, Cynthia D. Guy, Jiuyi Lu, Ayako Suzuki, James L. Burchette
The Journal of Pathology. 2011-07-01 - 100 citationsPediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1.Carlos E. Prada, Fatima A. Rangwala, Lisa J. Martin, Anne Lovell, Howard M. Saal
The Journal of Pediatrics. 2012-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
